Flagship V VentureLabs Rx Fund, L.P. - Insider Non-Derivative Transactions at Sana Biotechnology, Inc. (SANA) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Sep 13, 2023, Flagship V VentureLabs Rx Fund, L.P.'s relationship to Sana Biotechnology, Inc. (SANA) is TenPercentOwner, and currently has 8,615,337 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other SANA insiders.
Data Source: SEC.
Flagship V VentureLabs Rx Fund, L.P. - Insider Non-Derivative Transactions at SANA
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Sep 14, 2023 | J -- (Common Stock) | 1181745 | 0 | 0 |
| Sep 14, 2023 | J -- (Common Stock) | 70813 | 0 | 0 |
| Sep 14, 2023 | J -- (Common Stock) | 345069 | 0 | 1035208 |
| Sep 14, 2023 | J -- (Common Stock) | 2431281 | 0 | 7293841 |
| Sep 14, 2023 | J -- (Common Stock) | 4926378 | 0 | 8057470 |
| Sep 14, 2023 | J -- (Common Stock) | 2825989 | 0 | 8615337 |